|

AN9025 oral capsule Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Adlai Nortye Biopharma Co., Ltd.1

Indications

  • Solid Tumors (Phase 1)1
  • RAS Mutation1
  • Cancer1

Orlando, Florida1 trial

Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations

Sarah Cannon Research Institute at Florida Cancer Specialists

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.